Medtronic Approves Second Quarter Cash Dividend
The board of directors of Medtronic plc (NYSE: MDT) has taken an important step in affirming its commitment to shareholders by declaring a cash dividend of $0.71 per ordinary share for the second quarter of fiscal year 2026. This decision reflects a continuation of the company’s trend of increasing shareholder returns.
Commitment to Increasing Dividends
This quarterly dividend declaration comes after the announcement of a dividend increase that the company made earlier in 2025. Medtronic, recognized as a member of the S&P 500 Dividend Aristocrats index, has impressively increased its annual dividend for an astounding 48 consecutive years, highlighting its stability and reliability in delivering value to its investors.
Dividend Details and Schedule
The newly declared dividend will be distributed to shareholders on October 17, 2025. To qualify for this dividend, shareholders must hold shares by the close of business on September 26, 2025. This timeline ensures that shareholders have an opportunity to benefit from the ongoing financial strength of Medtronic.
About Medtronic plc
Medtronic is a global leader in healthcare technology. Headquartered in Galway, Ireland, it is dedicated to addressing some of the most pressing health issues facing the world today through innovative solutions. Medtronic’s mission is to alleviate pain, restore health, and extend lives, which is realized by a passionate global team of over 95,000 employees across more than 150 countries.
Medtronic offers a diverse array of technologies addressing 70 different health conditions, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems. Powered by an extensive base of knowledge and an eagerness to improve healthcare outcomes, Medtronic's innovative technologies are designed to transform lives, assisting two individuals every second with meaningful solutions.
Innovative Solutions for the Future
At Medtronic, innovation is at the heart of everything they do, ensuring that healthcare solutions are not just effective but also tailored to meet the needs of patients. This commitment to improvement drives Medtronic to create advanced tools and strategies that elevate patient care across the globe.
Growing Global Presence
With operations in a multitude of countries, Medtronic is well-positioned to deliver impactful healthcare solutions on a broader scale. The company continuously seeks to amplify its outreach and make healthcare accessibility a reality worldwide, allowing it to have a significant influence on health outcomes.
Contact Information
For further inquiries, Medtronic maintains active communication channels through their Public Relations and Investor Relations teams. The contacts for these departments are:
Erika Winkels
Public Relations
Phone: +1-763-526-8478
Ryan Weispfenning
Investor Relations
Phone: +1-763-505-4626
Frequently Asked Questions
What is the cash dividend amount announced by Medtronic?
Medtronic has announced a cash dividend of $0.71 per ordinary share for the second quarter of fiscal year 2026.
When will the dividend be paid?
The dividend is scheduled to be paid on October 17, 2025, to shareholders on record as of September 26, 2025.
How long has Medtronic been increasing its dividends?
Medtronic has successfully increased its annual dividend payment for 48 consecutive years.
Where is Medtronic headquartered?
Medtronic is headquartered in Galway, Ireland.
What types of medical solutions does Medtronic provide?
Medtronic provides a wide range of solutions including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems among many others.
